RNA editing of AZIN1 induces the malignant progression of non-small-cell lung cancers

Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas

(2016) Joshua D Campbell et al.   NATURE GENETICS

A role for antizyme inhibitor in cell proliferation

(2015) Tania M. Silva et al.   AMINO ACIDS

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers

(2015) Leng Han et al.   CANCER CELL

RNA over-editing of BLCAP contributes to hepatocarcinogenesis identified by whole-genome and transcriptome sequencing

(2015) Xueda Hu et al.   CANCER LETTERS

Frequent alterations in cytoskeleton remodelling genes in primary and metastatic lung adenocarcinomas

(2015) Kui Wu et al.   Nature Communications

Elevated RNA Editing Activity Is a Major Contributor to Transcriptomic Diversity in Tumors

(2015) Nurit Paz-Yaacov et al.   Cell Reports

Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome

(2015) Debora Fumagalli et al.   Cell Reports

RNA editing inRHOQpromotes invasion potential in colorectal cancer

(2014) Sae-Won Han et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Adenosine-to-Inosine RNA Editing Mediated by ADARs in Esophageal Squamous Cell Carcinoma

(2013) Y.-R. Qin et al.   CANCER RESEARCH

A-to-I RNA editing occurs at over a hundred million genomic sites, located in a majority of human genes

(2013) L. Bazak et al.   GENOME RESEARCH

A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma

(2013) Tim Hon Man Chan et al.   GUT

Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma

(2013) Leilei Chen et al.   NATURE MEDICINE

Cancer Genome Landscapes

(2013) B. Vogelstein et al.   SCIENCE

ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis

(2012) F Galeano et al.   ONCOGENE

Knockdown of antizyme inhibitor decreases prostate tumor growth in vivo

(2011) Rachelle R. Olsen et al.   AMINO ACIDS

Adenosine-to-inosine RNA editing meets cancer

(2011) D. Dominissini et al.   CARCINOGENESIS

Pathology of Lung Cancer

(2011) William D. Travis   CLINICS IN CHEST MEDICINE

Evidence of a Role for Antizyme and Antizyme Inhibitor as Regulators of Human Cancer

(2011) R. R. Olsen et al.   MOLECULAR CANCER RESEARCH

Functions and Regulation of RNA Editing by ADAR Deaminases

(2010) Kazuko Nishikura   Annual Review of Biochemistry

Assessing prostate cancer growth with mRNA of spermine metabolic enzymes

(2010) David Kaul et al.   CANCER BIOLOGY & THERAPY

Human ornithine decarboxylase paralogue (ODCp) is an antizyme inhibitor but not an arginine decarboxylase

(2007) Kristiina Kanerva et al.   BIOCHEMICAL JOURNAL